TY - JOUR
T1 - Comparison of Behavioral Effects of GABAergic Low- and High-Efficacy Neuroactive Steroids in the Zebrafish Larvae Assay
AU - Germann, Allison L.
AU - Xu, Yuanjian
AU - Covey, Douglas F.
AU - Evers, Alex S.
AU - Akk, Gustav
N1 - Publisher Copyright:
© 2024 American Chemical Society.
PY - 2024/3/6
Y1 - 2024/3/6
N2 - Activation of the GABAA receptor is associated with numerous behavioral end points ranging from anxiolysis to deep anesthesia. The specific behavioral effect of a GABAergic compound is considered to correlate with the degree of its functional effect on the receptor. Here, we tested the hypothesis that a low-efficacy allosteric potentiator of the GABAA receptor may act, due to a ceiling effect, as a sedative with reduced and limited action. We synthesized a derivative, named (3α, 5β)-20-methyl-pregnane-3, 20-diol (KK-235), of the GABAergic neurosteroid 5β-pregnane-3α, 20α-diol. Using electrophysiology, we showed that KK-235 is a low-efficacy potentiator of the synaptic-type α1β2γ2L GABAA receptor. In the zebrafish larvae behavioral assay, KK-235 was found to only partially block the inverted photomotor response (PMR) and to weakly reduce swimming behavior, whereas the high-efficacy GABAergic steroid (3α, 5α, 17β)-3-hydroxyandrostane-17-carbonitrile (ACN) fully blocked PMR and spontaneous swimming. Coapplication of KK-235 reduced the potentiating effect of ACN in an electrophysiological assay and dampened its sedative effect in behavioral experiments. We propose that low-efficacy GABAergic potentiators may be useful as sedatives with limited action.
AB - Activation of the GABAA receptor is associated with numerous behavioral end points ranging from anxiolysis to deep anesthesia. The specific behavioral effect of a GABAergic compound is considered to correlate with the degree of its functional effect on the receptor. Here, we tested the hypothesis that a low-efficacy allosteric potentiator of the GABAA receptor may act, due to a ceiling effect, as a sedative with reduced and limited action. We synthesized a derivative, named (3α, 5β)-20-methyl-pregnane-3, 20-diol (KK-235), of the GABAergic neurosteroid 5β-pregnane-3α, 20α-diol. Using electrophysiology, we showed that KK-235 is a low-efficacy potentiator of the synaptic-type α1β2γ2L GABAA receptor. In the zebrafish larvae behavioral assay, KK-235 was found to only partially block the inverted photomotor response (PMR) and to weakly reduce swimming behavior, whereas the high-efficacy GABAergic steroid (3α, 5α, 17β)-3-hydroxyandrostane-17-carbonitrile (ACN) fully blocked PMR and spontaneous swimming. Coapplication of KK-235 reduced the potentiating effect of ACN in an electrophysiological assay and dampened its sedative effect in behavioral experiments. We propose that low-efficacy GABAergic potentiators may be useful as sedatives with limited action.
KW - GABA receptor
KW - behavior
KW - function
KW - neuroactive steroids
KW - potentiation
KW - sedatives
UR - http://www.scopus.com/inward/record.url?scp=85186246395&partnerID=8YFLogxK
U2 - 10.1021/acschemneuro.3c00836
DO - 10.1021/acschemneuro.3c00836
M3 - Article
C2 - 38386612
AN - SCOPUS:85186246395
SN - 1948-7193
VL - 15
SP - 909
EP - 915
JO - ACS Chemical Neuroscience
JF - ACS Chemical Neuroscience
IS - 5
ER -